From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 160,000 shares, representing 41.84% for $1.14 million under the buyback announced on January 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5968 USD | -0.75% |
|
-16.23% | -95.37% |
Jul. 09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
Jul. 09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.37% | 10.42M | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-14.37% | 32.26B | |
+81.12% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+4.64% | 8.89B |
- Stock Market
- Equities
- TNXP Stock
- News Tonix Pharmaceuticals Holding Corp.
- Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on January 25, 2023.